Opella launches as an independent company to redefine the future of self-care
Egypt, 5 May 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of ...
Opella is the self-care challenger with third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people’s hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting.
At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world’s most loved brands, including Telfast, Doliprane, Bronchicum, Enterogermina, Maalox, Nasacort, Maxilase, Bisolvon or Buscopan. B Corp certified in multiple markets, we are active players in the journey towards healthier people and planet.
Egypt, 5 May 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of ...
Copyright © 2021 All Rights Reserved. Designed By INDELIGENT
Copyright © 2021 All Rights Reserved. Designed By INDELIGENT